Similar companies
Income Statement (CAD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 41M | 9.1% |
| Gross Profit | 14M | 1642.7% |
| Cost of Revenue | 27M | 29.8% |
| Operating expense | 19M | 18.8% |
| Net Income | 2.8M | 110.4% |
| EBITDA | -16M | 33.7% |
Balance Sheet (CAD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 355M | 6.9% |
| Total Liabilities | 59M | 1.8% |
| Total Equity | 296M | 8.9% |
| Shares Outstanding | 108M | 18.9% |
Cash Flow (CAD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | -2.5M | 69.6% |
| Cash from financing | 26M | 36.2% |
Financial Highlights for Organigram in Q2 '24
Organigram reported a revenue of 41M, which is a 9.1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 14M, marking a 1642.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 27M, a -29.8% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 19M, showing a -18.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 2.8M, showing a 110.4% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -16M, showing a 33.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Organigram with growth in revenue, gross profit, and net income.
